miR-141 targets ZEB2 to suppress HCC progression

Tumor Biology

Volumn 35, Issue 10, 2014, Pages 9993-9997

  Wu, Shi Min ^a,b   Ai, Hong Wu ^c   Zhang, Ding Yu ^b   Han, Xiao Qun ^b   Pan, Qin ^a   Luo, Feng Ling ^a   Zhang, Xiao Lian ^a  

^a WUHAN UNIVERSITY   (China)

^b Wuhan Medical Treatment Center   (China)

^c Wuhan Medical and Health Center for Women and Children   (China)

Author keywords

Growth; HCC; miR 141; Motility; ZEB2

Indexed keywords

HOMEODOMAIN PROTEIN; MICRORNA; MIRN141 MICRORNA, HUMAN; REPRESSOR PROTEIN; ZEB2 PROTEIN, HUMAN;

BIOSYNTHESIS; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HOMEODOMAIN PROTEINS; HUMANS; LIVER NEOPLASMS; MICRORNAS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84922391463     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2299-9     Document Type: Article

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90.
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003; 362: 1907-17.
3. Aravalli RN, Steer CJ, Cressman EN. Molecular mechanisms of hepatocellular carcinoma. Hepatology. 2008; 48: 2047-63.
4. Lee CH, KimJH, Lee SW. The role ofmicroRNAs in hepatitis c virus replication and related liver diseases. J Microbiol. 2014; 52: 445-51.
5. D'Anzeo M, Faloppi L, Scartozzi M, Giampieri R, Bianconi M, Del Prete M, et al. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment. Molecules. 2014; 19: 6393-406.
6. Shaikh F, Goff LW. Decoding hepatocellular carcinoma: the promise of microRNAs. Hepatobiliary Surgery Nutrition. 2014; 3: 93-4.
7. Zhang Z, Zheng W, Hai J. MicroRNA-148b expression is decreased in hepatocellular carcinoma and associated with prognosis. Med Oncol. 2014; 31: 984.
8. Liu YX, Long XD, Xi ZF, Ma Y, Huang XY, Yao JG, et al. MicroRNA-24 modulates aflatoxin b1-related hepatocellular carcinoma prognosis and tumorigenesis. BioMed Research International. 2014; 2014: 482926.
9. Parpart S, Roessler S, Dong F, RaoV, Takai A, Ji J, Qin LX, YeQH, Jia HL, Tang ZY, Wang XW: Modulation of mir-29 expression by alpha-fetoprotein is linked to the hepatocellular carcinoma epigenome. Hepatology 2014.
10. Jiang HL, Yu H, MaX, Xu D, Lin GF, MaDY, Jin JZ: MicroRNA-195 regulates steroid receptor coactivator-3 protein expression in hepatocellular carcinoma cells. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 2014.
11. Sheng Y, Li J, Zou C, Wang S, Cao Y, Zhang J, Huang A, Tang H: Downregulation of mir-101-3p by hepatitis b virus promotes proliferation and migration of hepatocellular carcinoma cells by targeting rab5a. Archives of virology 2014.
12. Li Y, Liang C, Ma H, Zhao Q, Lu Y, Xiang Z, et al. Mir-221/222 promotes s-phase entry and cellular migration in control of basal-like breast cancer. Molecules. 2014; 19: 7122-37.
13. Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y, et al. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the akt/foxo3a signaling pathway. Mol Cancer. 2014; 13: 109.
14. Zhang L, DongY, Zhu N, Tsoi H, Zhao Z, Wu CW, et al. MicroRNA-139-5p exerts tumor suppressor function by targeting notch1 in colorectal cancer. Mol Cancer. 2014; 13: 124.
15. Zhou J, Lu S, Yang S, Chen H, Shi H, Miao M, et al. MicroRNA-127 post-transcriptionally downregulates sept7 and suppresses cell growth in hepatocellular carcinoma cells. Cellular physiology and biochemistry. Int J Experimental Cellular Physiol, Biochem, Pharmacol. 2014; 33: 1537-46.
16. Zheng Q, Sheng Q, Jiang C, Shu J, Chen J, Nie Z, et al. MicroRNA-452 promotes tumorigenesis in hepatocellular carcinoma by targeting cyclin-dependent kinase inhibitor 1b. Mol Cell Biochem. 2014; 389: 187-95.
17. WangW, Lin H, Zhou L, Zhu Q, Gao S, Xie H, Liu Z, Xu Z, Wei J, Huang X, Zheng S: MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2013.
18. Yang X, Zhang XF, Lu X, Jia HL, Liang L, Dong QZ, et al. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cmet pathway. Hepatology. 2014; 59: 1874-85.
19. Li Q, Ding C, Chen C, Zhang Z, Xiao H, Xie F, et al. Mir-224 promotion of cellmigration and invasion by targeting homeobox d 10 gene in human hepatocellular carcinoma. J Gastroenterol Hepatol. 2014; 29: 835-42.
20. Banno K, Yanokura M, IidaM, Adachi M, Nakamura K, Nogami Y, Umene K, Masuda K, Kisu I, Nomura H, Kataoka F, Tominaga E, Aoki D: Application of microrna in diagnosis and treatment of ovarian cancer. BioMed research international 2014; 2014: 232817.
21. Diaz T, Tejero R, Moreno I, Ferrer G, Cordeiro A, Artells R, et al. Role of mir-200 family members in survival of colorectal cancer patients treated with fluoropyrimidines. J Surg Oncol. 2014; 109: 676-83.
22. Chen B, Huang T, Jiang J, Lv L, Li H, Xia S. Mir-141 suppresses proliferation and motility of gastric cancer cells by targeting hdgf. Mol Cell Biochem. 2014; 388: 211-8.
23. Chen X, Wang X, Ruan A, HanW, Zhao Y, Lu X, et al. Mir-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling epha2 expression. Clin Cancer Res: an Off J Am Assoc Cancer Research. 2014; 20: 2617-30.
24. Liu Y, Ding Y, Huang J, Wang S, Ni W, Guan J, et al. Mir-141 suppresses the migration and invasion of HCC cells by targeting tiam1. PLoS One. 2014; 9: e88393.
25. Browne G, Sayan AE, Tulchinsky E. Zeb proteins link cell motility with cell cycle control and cell survival in cancer. Cell Cycle. 2010; 9: 886-91.
26. Techasen A, Namwat N, LoilomeW, Duangkumpha K, Puapairoj A, Saya H, Yongvanit P: Tumor necrosis factor-alpha modulates epithelial mesenchymal transition mediators zeb2 and s100a4 to promote cholangiocarcinoma progression. Journal of hepato-biliarypancreatic sciences 2014.
27. Sun Z, Zhang Z, Liu Z, Qiu B, Liu K, Dong G. MicroRNA-335 inhibits invasion and metastasis of colorectal cancer by targeting zeb2. Med Oncol. 2014; 31: 982.
28. Guo F, Cogdell D, Hu L, Yang D, Sood AK, Xue F, et al. Mir-101 suppresses the epithelial-to-mesenchymal transition by targeting zeb1 and zeb2 in ovarian carcinoma. Oncol Rep. 2014; 31: 2021-8.
29. You J, Li Y, Fang N, Liu B, Zu L, Chang R, et al. Mir-132 suppresses the migration and invasion of lung cancer cells via targeting the emt regulator zeb2. PLoS One. 2014; 9: e91827.